Cargando…

The relationship between proton pump inhibitors and renal disease

Proton pump inhibitors (PPIs) bind to enzyme H(+)/K(+)-ATPase and inhibit its activity in the stomach, thus decreasing the secretion of gastric acid. PPIs may trigger acute interstitial nephritis, a potentially severe adverse event commonly associated with acute kidney injury. Studies have found tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morschel, Carine Franco, Mafra, Denise, Eduardo, José Carlos Carraro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Nefrologia 2018
Materias:	Update Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533960/ https://www.ncbi.nlm.nih.gov/pubmed/30010692 http://dx.doi.org/10.1590/2175-8239-JBN-2018-0021

Ejemplares similares

A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors
por: Kume, Shinji, et al.
Publicado: (2022)

The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial
por: Shakur, Haleema, et al.
Publicado: (2016)

ACQUIRED PES CAVUS IN CHARCOT-MARIE-TOOTH DISEASE
por: Maranho, Daniel Augusto, et al.
Publicado: (2015)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Association between proton pump inhibitors and periodontal disease severity
por: Chawla, Bhavneet K., et al.
Publicado: (2021)

Is There a Genetic Relationship Between Alcoholism and Depression?
por: Nurnberger, John I., et al.
Publicado: (2002)

Fgl2: link between hepatitis B and SARS?
por: Robertson, Morag
Publicado: (2003)

Association of proton pump inhibitor use with renal outcomes in patients with coronary artery disease
por: Cho, Nam-Jun, et al.
Publicado: (2018)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Update to the study protocol, including statistical analysis plan, for the multicentre, randomised controlled OuTSMART trial: a combined screening/treatment programme to prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies
por: Stringer, Dominic, et al.
Publicado: (2019)

Impact of the Changes in the End Stage Renal Disease Composite Rate
Publicado: (1989)

Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019
por: Feitosa-Filho, Gilson Soares, et al.
Publicado: (2019)

Lessons learnt during a complex, multicentre cluster randomised controlled trial: the ProAct65+ trial
por: Stevens, Zoe, et al.
Publicado: (2013)

Update of the Brazilian Guideline on Nuclear Cardiology - 2020
por: Mastrocola, Luiz Eduardo, et al.
Publicado: (2020)

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson’s disease
por: Foltynie, Tom, et al.
Publicado: (2023)

OSTEOSYNTHESIS WITH INTRAMEDULLARY NAILS IN CHILDREN
por: Alvachian Fernandes, Helio Jorge, et al.
Publicado: (2015)

Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease
por: Arj, Abbas, et al.
Publicado: (2022)

Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids—What Is the Relationship?
por: McCarthy, Denis M.
Publicado: (2020)

Barriers impacting the POINT pragmatic trial: the unavoidable overlap between research and intervention procedures in “real-world” research
por: Dir, Allyson L., et al.
Publicado: (2021)

Monitoring clinical progression with mitochondrial disease biomarkers
por: Steele, Hannah E, et al.
Publicado: (2017)

RELATIONSHIP BETWEEN TBS SCORE, BONE DENSITY AND FRACTURES IN OLDER MEN: INTEGRATIVE REVIEW
por: BORBA, ALEXANDRE COUTINHO, et al.
Publicado: (2022)

Current status of diabetic kidney disease and latest trends in management
por: Kim, Min Kyung, et al.
Publicado: (2022)

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
por: Betts, Matthew J, et al.
Publicado: (2019)

Recent updates in factors associated with incidence and screening of diabetic eye disease
por: Sone, Hirohito
Publicado: (2023)

Detection of inflammatory bowel disease: diagnostic performance of cross-sectional imaging modalities
por: Horsthuis, Karin, et al.
Publicado: (2007)

Detecting new neurodegenerative disease genes: does phenotype accuracy limit the horizon?
por: Samuels, David C., et al.
Publicado: (2009)

Statistical analysis plan for the Prophylactic Melatonin for Delirium in Intensive Care (ProMEDIC): a randomised controlled trial
por: Wibrow, Bradley, et al.
Publicado: (2021)

BENIGN BONE TUMORS AND TUMOR-LIKE BONE LESIONS: TREATMENT UPDATE AND NEW TRENDS
por: Nogueira Drumond, José Marcos
Publicado: (2015)

Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients
por: Flothow, Dominik J. G., et al.
Publicado: (2020)

Association between Parkinson's disease and proton pump inhibitors therapy in older people
por: Lai, Shih-Wei, et al.
Publicado: (2020)

AZTEC—azithromycin therapy for prevention of chronic lung disease of prematurity: a statistical analysis plan for clinical outcomes
por: Lau, Tin Man Mandy, et al.
Publicado: (2022)

Statistical analysis plan for the motor neuron disease systematic multi-arm adaptive randomised trial (MND-SMART)
por: Parker, Richard A., et al.
Publicado: (2023)

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
por: Précoma, Dalton Bertolim, et al.
Publicado: (2019)

Effectiveness of the Shenzhuo formula in the treatment of patients with macroalbuminuria secondary to diabetic kidney disease: protocol update and statistical analysis plan
por: Wei, Yu, et al.
Publicado: (2022)

Putting Out the Fire: The Relationship of Pharmacogenetics and Proton Pump Inhibitors for the Treatment of Gastroesophageal Reflux Disease
por: Zheng, Connor L, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_88jeha6h9c5jl337k3jgg7pqk3